All Stories

  1. Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility
  2. Molecular Identification of Saprochaete capitata in Human Blood and Paraffinized Tissue Samples
  3. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases
  4. Humoral Immunity Links Candida albicans Infection and Celiac Disease
  5. Identification and characterization of nine atypical Candida dubliniensis clinical isolates
  6. Candida albicansand cancer: Can this yeast induce cancer development or progression?
  7. Candidaantigens and immune responses: implications for a vaccine
  8. Anabolic steroids affect human periodontal health and microbiota
  9. Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: Report of five cases and review of the antifungal therapy
  10. Production of carcinogenic acetaldehyde byCandida albicansfrom patients with potentially malignant oral mucosal disorders
  11. Pga13 in Candida albicans is localized in the cell wall and influences cell surface properties, morphogenesis and virulence
  12. Periodontopathogen and Epstein-Barr Virus Contamination Affects Transplanted Bone Volume in Sinus Augmentation
  13. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease
  14. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d-...
  15. Bone Microbial Decontamination Agents in Osseous Grafting: An In Vitro Study With Fresh Human Explants
  16. Fungicidal Monoclonal Antibody C7 Interferes with Iron Acquisition in Candida albicans
  17. The Impact of Oral Contraceptives on Women's Periodontal Health and the Subgingival Occurrence of Aggressive Periodontopathogens and Candida Species
  18. Potential of anti-Candida antibodies in immunoprophylaxis
  19. Bone Microbial Contamination Influences Autogenous Grafting in Sinus Augmentation
  20. Monoclonal antibody-mediated inhibition of adhesion ofCandida albicansandCandida dubliniensisto human epithelial cells
  21. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity
  22. P1.104. A preliminary study on the characteristics of the fungal strains colonizing over oral lichenoid disease lesions
  23. Detection of (1→3)-β-d-Glucan as an Adjunct to Diagnosis in a Mixed Population with Uncommon Proven Invasive Fungal Diseases or with an Unusual Clinical Presentation
  24. Aislamiento de Aspergillus lentulus en España en un paciente crítico con enfermedad pulmonar obstructiva crónica
  25. Use of a Serum (1→3)‐β‐d‐Glucan Assay for Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia
  26. Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities
  27. Contribution of serum biomarkers to the diagnosis of invasive candidiasis
  28. Use of Recombinant Antigens for the Diagnosis of Invasive Candidiasis
  29. Identificación rápida de Candida dubliniensis mediante la prueba Bichro-Dubli®
  30. Fungicidal Monoclonal Antibody C7 Binds to Candida albicans Als3
  31. Evaluation of a Novel Enzyme-Linked Immunosorbent Assay To Detect Immunoglobulin G Antibody to Enolase for Serodiagnosis of Invasive Candidiasis
  32. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1
  33. In Vitro Activities of Voriconazole and Five Licensed Antifungal Agents Against Candida dubliniensis: Comparison of CLSI M27-A2, Sensititre YeastOne, Disk Diffusion, and Etest Methods
  34. Evaluation of the New Chromogenic Medium Candida ID 2 for Isolation and Identification of Candida albicans and Other Medically Important Candida Species
  35. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans
  36. Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma
  37. A Fungicidal Monoclonal Antibody Protects against Murine Invasive Candidiasis
  38. Usefulness of Candida ID2 agar for the presumptive identification ofCandida dubliniensis
  39. Supplementation of CHROMagar Candida Medium with Pal's Medium for Rapid Identification of Candida dubliniensis
  40. Serodiagnosis of Mycoses Using Recombinant Antigens
  41. Oral Candida Isolates Colonizing or Infecting Human Immunodeficiency Virus-Infected and Healthy Persons in Mexico
  42. Antifungal and Antitumor Activities of a Monoclonal Antibody Directed Against a Stress Mannoprotein of Candida albicans
  43. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis
  44. Developing chick embryos express a protein which shares homology with the nuclear pore complex protein Nup88 present in human tumors
  45. A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities
  46. Casein Agar: a Useful Medium for Differentiating Candida dubliniensis from Candida albicans
  47. Serological Differentiation of Experimentally Induced Candida dubliniensis and Candida albicans Infections
  48. Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6
  49. Effect of n-Alkanols on Acidification Curves of Aureobasidium pullulans Suspensions
  50. Morphogenetic potency of short-chainn-alkanols related toAureobasidium pullulans dimorphism
  51. Growth and macromolecular content of the dimorphic fungus Aureobasidium pullulans and the effect of hydroxyurea and other inhibitors